The funding will be spread over four years, with BXLS also eligible for regulatory and commercial milestones, plus royalties on worldwide sales
Aster DM Healthcare and Quality Care India Limited have signed definitive agreements to merge, subject to regulatory, corporate and shareholders’ approvals
The investment will accelerate the overall Sarclisa development program
The endorsement follows overwhelming support for the share swap preceding the merger,
Under the proposed terms, Vaximm would secure a $20 million upfront payment, up to $815 million tied to clinical, regulatory, and commercial milestones
The merged entity ‘Aster DM Quality Care’ will be jointly controlled by Aster Promoters and Blackstone
Acquisition expands Merck’s growing hematology portfolio
Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate
The Pune centre expands its presence beyond Bangalore and Hyderabad
Subscribe To Our Newsletter & Stay Updated
